Display Settings:

Format

Send to:

Choose Destination

    Science. 1995 Mar 17;267(5204):1638-41.

    Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.

    Dessen A, Quémard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC.

    Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461.

    Resistance to isoniazid in Mycobacterium tuberculosis can be mediated by substitution of alanine for serine 94 in the InhA protein, the drug's primary target. InhA was shown to catalyze the beta-nicotinamide adenine dinucleotide (NADH)-specific reduction of 2-trans-enoyl-acyl carrier protein, an essential step in fatty acid elongation. Kinetic analyses suggested that isoniazid resistance is due to a decreased affinity of the mutant protein for NADH. The three-dimensional structures of wild-type and mutant InhA, refined to 2.2 and 2.7 angstroms, respectively, revealed that drug resistance is directly related to a perturbation in the hydrogen-bonding network that stabilizes NADH binding.

    PMID: 7886450 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Structures reported by this article

    Patient drug information